Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 773103

Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients


Grbeša, Ivana; Pajares, María J.; Martínez- Terroba, Elena; Agorreta, Jackeline; Mikecin, Ana-Matea; Larráyoz, Marta; Idoate, Miguel A.; Gall Trošelj, Koraljka; Pio, Ruben; Montuenga, Luis M.
Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients // PLoS One, 10 (2015), 4; e0124670-1 doi:10.1371/journal.pone.0124670 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 773103 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients

Autori
Grbeša, Ivana ; Pajares, María J. ; Martínez- Terroba, Elena ; Agorreta, Jackeline ; Mikecin, Ana-Matea ; Larráyoz, Marta ; Idoate, Miguel A. ; Gall Trošelj, Koraljka ; Pio, Ruben ; Montuenga, Luis M.

Izvornik
PLoS One (1932-6203) 10 (2015), 4; E0124670-1

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
SIRT1; SIRT2; lung cancer; prognosis

Sažetak
Sirtuin 1 (SIRT1) and sirtuin 2 (SIRT2) are NAD+-dependent protein deacetylases involved in the regulation of key cancer-associated genes. In this study we evaluated the relevance of these deacetylases in lung cancer biology. Protein levels of SIRT1 and SIRT2 were determined in non-small cell lung cancer (NSCLC) cell lines and primary tumors from 105 patients. Changes in proliferation were assessed after SIRT1 and SIRT2 downregulation in lung cancer cell lines using siRNA-mediated technology or tenovin-1, a SIRT1 and SIRT2 inhibitor. High SIRT1 and SIRT2 protein levels were found in NSCLC cell lines compared with non-tumor lung epithelial cells. The expression of SIRT1 and SIRT2 proteins was also significantly higher in lung primary tumors than in normal tissue (P<0.001 for both sirtuins). Stronger nuclear SIRT1 staining was observed in adenocarcinomas than in squamous cell carcinomas (P=0.033). Interestingly, in NSCLC patients, high SIRT1 and SIRT2 expression levels were associated with shorter recurrence- free survival (P=0.04 and P=0.007, respectively). Moreover, the combination of high SIRT1 and SIRT2 expression was an independent prognostic factor for shorter recurrence-free survival (P=0.002) and overall survival (P=0.022). In vitro studies showed that SIRT1 and/or SIRT2 downregulation significantly decreased proliferation of NSCLC. Our results support the hypothesis that SIRT1 and SIRT2 have a protumorigenic role in lung cancer, promoting cell proliferation. Moreover, the expression of these proteins is associated with poor prognosis in NSCLC patients and may help to identify those NSCLC patients with high risk of recurrence that could benefit from adjuvant therapy after resection.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Institut "Ruđer Bošković", Zagreb

Poveznice na cjeloviti tekst rada:

doi fulir.irb.hr www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Grbeša, Ivana; Pajares, María J.; Martínez- Terroba, Elena; Agorreta, Jackeline; Mikecin, Ana-Matea; Larráyoz, Marta; Idoate, Miguel A.; Gall Trošelj, Koraljka; Pio, Ruben; Montuenga, Luis M.
Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients // PLoS One, 10 (2015), 4; e0124670-1 doi:10.1371/journal.pone.0124670 (međunarodna recenzija, članak, znanstveni)
Grbeša, I., Pajares, M., Martínez- Terroba, E., Agorreta, J., Mikecin, A., Larráyoz, M., Idoate, M., Gall Trošelj, K., Pio, R. & Montuenga, L. (2015) Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients. PLoS One, 10 (4), e0124670-1 doi:10.1371/journal.pone.0124670.
@article{article, author = {Grbe\v{s}a, Ivana and Pajares, Mar\'{\i}a J. and Mart\'{\i}nez- Terroba, Elena and Agorreta, Jackeline and Mikecin, Ana-Matea and Larr\'{a}yoz, Marta and Idoate, Miguel A. and Gall Tro\v{s}elj, Koraljka and Pio, Ruben and Montuenga, Luis M.}, year = {2015}, pages = {e0124670-1-e0124670-17}, DOI = {10.1371/journal.pone.0124670}, keywords = {SIRT1, SIRT2, lung cancer, prognosis}, journal = {PLoS One}, doi = {10.1371/journal.pone.0124670}, volume = {10}, number = {4}, issn = {1932-6203}, title = {Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients}, keyword = {SIRT1, SIRT2, lung cancer, prognosis} }
@article{article, author = {Grbe\v{s}a, Ivana and Pajares, Mar\'{\i}a J. and Mart\'{\i}nez- Terroba, Elena and Agorreta, Jackeline and Mikecin, Ana-Matea and Larr\'{a}yoz, Marta and Idoate, Miguel A. and Gall Tro\v{s}elj, Koraljka and Pio, Ruben and Montuenga, Luis M.}, year = {2015}, pages = {e0124670-1-e0124670-17}, DOI = {10.1371/journal.pone.0124670}, keywords = {SIRT1, SIRT2, lung cancer, prognosis}, journal = {PLoS One}, doi = {10.1371/journal.pone.0124670}, volume = {10}, number = {4}, issn = {1932-6203}, title = {Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients}, keyword = {SIRT1, SIRT2, lung cancer, prognosis} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font